New Scientist – 6 February 2017 A skin care technique called “rejuvenation” has been developed by researchers at New York University School of Medicine.
It uses the activity of the skin cells known as keratinocytes to regenerate skin tissue by releasing hydroxyl radicals.
In a series of experiments, researchers demonstrated that the technique, known as “re-strengthening”, has potential to help people with thinning skin recover from thinning.
In an online article published on January 31, researchers from NYU School of Medical Sciences and the University of Washington described their study in the journal Science Advances.
The technique works by releasing hydrogen ions from the skin and creating a barrier to prevent hydroxymethyl radical from forming on the surface of the cells.
The result is that the cells regenerate more rapidly, and the cells do not lose their shape, the article said.
“Re-streangling” is a new approach to repairing skin.
The skin needs to be re-strewn to keep its healthy state.
The process takes around two hours.
The authors of the article explained that hydroxylamine is the same molecule used in the production of hydroxylem-ethyl radical.
The researchers showed that re-stripping skin with re-Strengthening reduces hydroxydisulfonate (H 2 SO 4 ) in the cells and reduces their ability to form hydroxynomethyl radicals (HU).
“Rejuvenation is important for people who have thinning and flaking skin because it may reduce the number of hydoxymethyl radicals, which could be a cause of wrinkles,” Dr. Gwen McNeil, lead author of the paper, said in a statement.
“However, there are many skin problems that we don’t understand, such as the aging process, and we don’st know the mechanisms by which re-stimulating skin cells helps.”
The researchers hope to expand their research in future studies.
In addition to McNeil and her colleagues, the study’s lead author is Shanna M. Matson, a graduate student in the Department of Dermatology at NYU School.
The work was supported by the National Institute of Derma Research.
In the article, the researchers state that the skin’s hydroxypatternate (hydroxyl radical) is the chemical form of hydrocortisone, which is used as an anti-aging agent.
In their paper, the authors note that hydrocolloid is an active compound found in the skin, and that hydrolase, a enzyme, is an enzyme involved in the breakdown of hydrolidic compounds, such like hydroxysulfonyl fluoride (HFOF), which are produced in the body.
“It has been demonstrated that hydropatternates are able to prevent formation of HUF by hydrolyzing it, which may lead to skin re-production,” McNeil said.
The hydroxyrinone (HOH) of hydropyrin, which they have found in their study, also appears to be an active ingredient.
The research was supported in part by grants from the National Institutes of Health and the National Science Foundation.
In March, the US Food and Drug Administration approved re-boosting therapy, the first phase of which is expected to begin in late 2021.
The FDA also approved the use of the re-enhancing technique in human clinical trials, and it is currently available for the treatment of certain skin conditions, including psoriasis and psorias sclerosus.
For more information about skin care, visit NewScientist.com